Patent details

EP2892904 Title: HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS

Basic Information

Publication number:
EP2892904
PCT Application Number:
CN2013080598
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138325873
PCT Publication Number:
WO2014032498
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS
French Title of Invention:
INHIBITEURS HAUTEMENT SÉLECTIFS DE C-MET UTILISÉS COMME AGENTS ANTICANCÉREUX
German Title of Invention:
HOCHSELEKTIVE C-MET-HEMMER ALS ANTIKREBSMITTEL
SPC Number:

Dates

Filing date:
01/08/2013
Grant date:
17/10/2018
EP Publication Date:
15/07/2015
PCT Publication Date:
06/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/10/2018
EP B1 Publication Date:
17/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/08/2019
Expiration date:
01/08/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/10/2018
 
 

Name:
CB Therapeutics Inc.
Address:
c/o Codan Trust Company (Cayman) Limited Boundary Hall, 2nd Floor Cricket Square, PO Box 2681, Grand Cayman KY1-1111, Cayman Islands (KY)

Inventor

1

Name:
ZHOU, Feng
Address:
China (CN)

2

Name:
ZHONG, Boyu
Address:
China (CN)

3

Name:
YUAN, Hongbin
Address:
China (CN)

4

Name:
SHIH, Chuan
Address:
China (CN)

Priority

Priority Number:
201210322359
Priority Date:
03/09/2012
Priority Country:
China (CN)

Classification

IPC classification:
A61K 31/5025; A61P 35/00; C07D 471/04; C07D 487/04; C07D 513/04;

Publication

European Patent Bulletin

Issue number:
201842
Publication date:
17/10/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages